Algernon Pharmaceuticals's total assets for Q3 2025 were C$4.88M, an increase of 44.50% from the previous quarter. AGNPF total liabilities were C$3.14M for the fiscal quarter, a 60.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.